Alligator Bioscience AB - Redeye

More documents

Recommendations

Info

ADC-1015 Bispecific antibody 18 CONFIDENTIAL
ADC-1015: A Bispecific Immune Activator <strong>Alligator</strong> is developing a bispecific immune activating antibody for local treatment of metastasizing cancer - ADC-1015. Ø Superior to combination of two monospecific compounds Ø Novelty – strong IP can be obtained 19 CONFIDENTIAL
Page 1 and 2: Alligator Bioscience AB Cancer Immu
Page 3 and 4: Technology & Product Growth FIND ®
Page 5 and 6: Immunotherapy of Cancer 5 CONFIDENT
Page 7 and 8: Local Immunotherapy: Competitive Ed
Page 9 and 10: Designing ADC-1013 for Local Immuno
Page 11 and 12: 1. Systemic Anti-Tumor Effect Twin
Page 13 and 14: 2. Long Term Immunity Cured mice re
Page 15 and 16: Transgenic Mice Transgenic mice - g
Page 17: ADC-1013 Status and Development Pla
Page 21 and 22: World Class Key Opinion Leaders All
Page 23 and 24: Financing Needs Rest of 2013 Ø Ong
Page 25: Share Capital - February 18, 2013 S

Alligator Bioscience AB - Redeye

Create successful ePaper yourself

Delete template?

Save as template?